Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Josephson

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Journal of Clinical Pharmacology|March 1, 1988
Hemodynamic effects of flestolol, a titratable short-acting intravenous beta-adrenergic receptor blockerJ Strom, M Josephson, W H Frishman, et al.
Tissue & Cell|July 20, 2017
Ecto-5'-nucleotidase (CD73) regulates bone formation and remodeling during intramembranous bone repair in aging miceVivian Bradaschia-Correa, Anne M Josephson, Alexander J Egol, et al.
Journal of the American College of Cardiology|February 1, 1989
Fractionated endocardial electrograms are associated with slow conduction in humans: evidence from pace-mappingW G Stevenson, J N Weiss, I Wiener, et al.
Human Pathology|March 7, 2001
The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsiesS M Meehan, P Domer, M Josephson, et al.
Clinical Chemistry|February 1, 1987
Plasma iron and transferrin iron-binding capacity evaluated by colorimetric and immunoprecipitation methodsH A Huebers, M J Eng, B M Josephson, et al.
Scientific Reports|March 27, 2019
Hox gene expression determines cell fate of adult periosteal stem/progenitor cellsVivian Bradaschia-Correa, Kevin Leclerc, Anne M Josephson, et al.
Scientific Reports|February 19, 2020
Author Correction: Hox gene expression determines cell fate of adult periosteal stem/progenitor cellsVivian Bradaschia-Correa, Kevin Leclerc, Anne M Josephson, et al.
Circulation|November 11, 1991
Predictors of in-hospital mortality after DC catheter ablation of atrioventricular junction. Results of a prospective, international, multicenter studyG T Evans, M M Scheinman, G Bardy, et al.
Clinical Transplantation|August 1, 1996
OKT3 escalating dose regimens provide effective therapy for renal allograft rejectionE S Woodle, D S Bruce, M Josephson, et al.
Clinical Transplantation|August 1, 1996
FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantationE S Woodle, D S Bruce, M Josephson, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Journal of Clinical Pharmacology|March 1, 1988
Hemodynamic effects of flestolol, a titratable short-acting intravenous beta-adrenergic receptor blockerJ Strom, M Josephson, W H Frishman, et al.
Tissue & Cell|July 20, 2017
Ecto-5'-nucleotidase (CD73) regulates bone formation and remodeling during intramembranous bone repair in aging miceVivian Bradaschia-Correa, Anne M Josephson, Alexander J Egol, et al.
Journal of the American College of Cardiology|February 1, 1989
Fractionated endocardial electrograms are associated with slow conduction in humans: evidence from pace-mappingW G Stevenson, J N Weiss, I Wiener, et al.
Human Pathology|March 7, 2001
The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsiesS M Meehan, P Domer, M Josephson, et al.
Clinical Chemistry|February 1, 1987
Plasma iron and transferrin iron-binding capacity evaluated by colorimetric and immunoprecipitation methodsH A Huebers, M J Eng, B M Josephson, et al.
Scientific Reports|March 27, 2019
Hox gene expression determines cell fate of adult periosteal stem/progenitor cellsVivian Bradaschia-Correa, Kevin Leclerc, Anne M Josephson, et al.
Scientific Reports|February 19, 2020
Author Correction: Hox gene expression determines cell fate of adult periosteal stem/progenitor cellsVivian Bradaschia-Correa, Kevin Leclerc, Anne M Josephson, et al.
Circulation|November 11, 1991
Predictors of in-hospital mortality after DC catheter ablation of atrioventricular junction. Results of a prospective, international, multicenter studyG T Evans, M M Scheinman, G Bardy, et al.
Clinical Transplantation|August 1, 1996
OKT3 escalating dose regimens provide effective therapy for renal allograft rejectionE S Woodle, D S Bruce, M Josephson, et al.
Clinical Transplantation|August 1, 1996
FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantationE S Woodle, D S Bruce, M Josephson, et al.
Pageof 11